Skip to main content
OpenTrials

Clinical trial condition

Embolism and Thrombosis

Explore clinical trials studying Embolism and Thrombosis. Study availability and eligibility vary by location and protocol.

2,300 public trials 310 recruiting studies
Refine in advanced search Browse all conditions

Embolism and Thrombosis trial results

Completed

Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph

NCT04723160

Conditions
Arterial Occlusive Diseases, Cardiovascular Diseases, Central Serous Chorioretinopathy, +32 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Tianjin Medical University Eye Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Completed

TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT03093701

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +6 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Retina Institute of California Arcadia, California, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retina Institute of California Palm Desert, California, United States
View all 20 locations
View Trial Details
Completed

ATHN 2: Factor Switching Study

NCT02546622

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +14 more
Locations
  • University of California San Diego (UCSD) San Diego, California, United States
  • University of Colorado Denver Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Yale Hemophilia Treatment Center New Haven, Connecticut, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 27 locations
View Trial Details
Completed

A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

NCT01388491

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Hemostasis, +3 more
Locations
  • Teva Investigational Site 32064 Essen, Germany
  • Teva Investigational Site 32065 Frankfurt, Germany
  • Teva Investigational Site 32066 Frankfurt am Main, Germany
  • Teva Investigational Site 32062 Hamburg, Germany
View all 27 locations
View Trial Details

Related conditions